Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Truist Financial
TFC
|
+$233M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$133M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$131M |
| 4 |
Bank of America
BAC
|
+$85.7M |
| 5 |
Onto Innovation
ONTO
|
+$64.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$469M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$228M |
| 3 |
CELG
Celgene Corp
CELG
|
+$198M |
| 4 |
Walmart
WMT
|
+$177M |
| 5 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$172M |
Sector Composition
| 1 | Financials | 18.98% |
| 2 | Technology | 14.1% |
| 3 | Industrials | 13.03% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Healthcare | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VEDL
2101
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $17.9M | 0.01% |
2,073,789
-197,561
| -9% | -$1.71M |
|
2102
Village Super Market
VLGEA
$580M
| $17.9M | 0.01% |
771,273
+856
| +0.1% | +$19.9K |
|
|
BLUE
2103
DELISTED
bluebird bio
BLUE
| $17.8M | 0.01% |
15,672
-112
| -0.7% | -$127K |
|
|
DLA
2104
DELISTED
Delta Apparel Inc.
DLA
| $17.8M | 0.01% |
572,736
-5,742
| -1% | -$179K |
|
|
GTY
2105
Getty Realty Corp
GTY
$1.6B
| $17.7M | 0.01% |
537,558
+7,315
| +1% | +$240K |
|
2106
Timberland Bancorp
TSBK
$288M
| $17.7M | 0.01% |
593,924
-4,210
| -0.7% | -$125K |
|
2107
Travere Therapeutics
TVTX
$2.09B
| $17.6M | 0.01% |
1,239,881
-788
| -0.1% | -$11.2K |
|
|
ORBC
2108
DELISTED
ORBCOMM, Inc.
ORBC
| $17.6M | 0.01% |
4,171,367
+143,905
| +4% | +$606K |
|
|
NE
2109
DELISTED
Noble Corporation
NE
| $17.5M | 0.01% |
14,317,653
-1,860,833
| -12% | -$2.27M |
|
|
EGRX
2110
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $17.4M | 0.01% |
289,244
+16,034
| +6% | +$963K |
|
2111
MidWestOne Financial Group
MOFG
$604M
| $17.3M | 0.01% |
478,323
+22,778
| +5% | +$825K |
|
2112
Covenant Logistics
CVLG
$576M
| $17.3M | 0.01% |
2,680,494
-6,984
| -0.3% | -$45.1K |
|
2113
Virtu Financial
VIRT
$3.1B
| $17.3M | 0.01% |
1,081,895
+100,829
| +10% | +$1.61M |
|
2114
WisdomTree
WT
$2.11B
| $17.2M | 0.01% |
3,552,440
+180,552
| +5% | +$874K |
|
|
WAAS
2115
DELISTED
AquaVenture Holdings Limited
WAAS
| $17.2M | 0.01% |
632,844
+80,351
| +15% | +$2.18M |
|
|
LGTY
2116
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $17.1M | 0.01% |
1,147,922
-19,589
| -2% | -$291K |
|
2117
Nicolet Bankshares
NIC
$2B
| $17.1M | 0.01% |
231,151
+2,797
| +1% | +$207K |
|
2118
Atlanta Braves Holdings Series B
BATRK
$2.64B
| $17.1M | 0.01% |
577,840
+59,448
| +11% | +$1.76M |
|
|
CAMP
2119
DELISTED
CalAmp Corp.
CAMP
| $17.1M | 0.01% |
77,419
-1,230
| -2% | -$271K |
|
2120
Titan International
TWI
$552M
| $17M | 0.01% |
4,705,334
-66,440
| -1% | -$241K |
|
2121
BankFinancial
BFIN
$153M
| $17M | 0.01% |
1,301,626
-36,637
| -3% | -$479K |
|
|
HTB
2122
HomeTrust Bancshares, Inc.
HTB
$713M
| $17M | 0.01% |
632,248
-9,627
| -1% | -$258K |
|
|
ZAGG
2123
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $17M | 0.01% |
2,090,459
+31,758
| +2% | +$258K |
|
2124
Surgery Partners
SGRY
$2.8B
| $16.9M | 0.01% |
1,080,657
+226,841
| +27% | +$3.55M |
|
2125
Madrigal Pharmaceuticals
MDGL
$9.63B
| $16.9M | 0.01% |
185,544
+70,222
| +61% | +$6.4M |
|